- Home
- BJDX vs CNSP Comparison
BJDX vs CNSP Comparison
Compare BJDX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- CNSP
- Stock Information
- Founded
- BJDX 2015
- CNSP 2017
- Country
- BJDX United States
- CNSP United States
- Employees
- BJDX N/A
- CNSP N/A
- Industry
- BJDX Medical Specialities
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- BJDX Health Care
- CNSP Health Care
- Exchange
- BJDX Nasdaq
- CNSP Nasdaq
- Market Cap
- BJDX 3.9M
- CNSP 4.0M
- IPO Year
- BJDX 2021
- CNSP 2019
- Fundamental
- Price
- BJDX $1.70
- CNSP $8.13
- Analyst Decision
- BJDX
- CNSP Strong Buy
- Analyst Count
- BJDX 0
- CNSP 1
- Target Price
- BJDX N/A
- CNSP $20.00
- AVG Volume (30 Days)
- BJDX 103.5K
- CNSP 18.4K
- Earning Date
- BJDX 11-07-2025
- CNSP 11-12-2025
- Dividend Yield
- BJDX N/A
- CNSP N/A
- EPS Growth
- BJDX N/A
- CNSP N/A
- EPS
- BJDX N/A
- CNSP N/A
- Revenue
- BJDX N/A
- CNSP N/A
- Revenue This Year
- BJDX N/A
- CNSP N/A
- Revenue Next Year
- BJDX $55.56
- CNSP N/A
- P/E Ratio
- BJDX N/A
- CNSP N/A
- Revenue Growth
- BJDX N/A
- CNSP N/A
- 52 Week Low
- BJDX $1.26
- CNSP $4.93
- 52 Week High
- BJDX $10.20
- CNSP $114.00
- Technical
- Relative Strength Index (RSI)
- BJDX 41.64
- CNSP 40.01
- Support Level
- BJDX $1.39
- CNSP $6.13
- Resistance Level
- BJDX $2.34
- CNSP $8.86
- Average True Range (ATR)
- BJDX 0.17
- CNSP 0.59
- MACD
- BJDX -0.10
- CNSP -0.12
- Stochastic Oscillator
- BJDX 28.16
- CNSP 22.34
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.